NCT03883945: An ongoing trial by Aiviva BioPharma Inc.
This trial is ongoing. It must report results 2 years, 4 months from now.
|Full entry on ClinicalTrials.gov||NCT03883945|
|Title||A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Intradermally Administered AIV001 in Subjects With Papulopustular Rosacea|
|ACT or pACT?||This is what FDAAA officially calls an "Applicable Clinical Trial"|
|Start date||Dec. 31, 2020|
|Completion date||Dec. 31, 2021|
|Required reporting date||Dec. 31, 2022, midnight|
|Actual reporting date||None|
|Date last checked at ClinicalTrials.gov||July 30, 2020|